AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

says Michael Baker, Head of Process Development at FUJIFILM Diosynth Biotechnologies. The company already runs a gene therapy manufacturing facility in College Station, Texas that meets the FDA ...

Yet success brings new obstacles, and after overcoming decades of setbacks, gene therapy’s pioneers face the challenge of manufacturing cutting-edge treatments at scale. The linchpin of every ...

This overview will cover these topics through the process of bringing a new product ... Explain what steps are involved for getting a gene therapy product to the clinic. 3. Discuss development and ...

To use AAVs for clinical gene therapy applications, they must be produced in sufficient quantities to meet clinical demand. However, setting up and optimizing AAV production is a meticulous process.

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs ... and updates in cell therapy regulation The importance of partnerships within the CGT ecosystem Deciding on a commercially ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

However, significant barriers stand in the way of realising this promise on a worldwide scale, from manufacturing costs and ...

Abigail Beaney (AB): What is the biggest pain point within the manufacturing ... speed up cell and gene therapy access and what role will automation play in that process? ME: One of the first ...

Beam Therapeutics Inc. (NASDAQ:BEAM)’s newly developed automated CD34+ cell process for BEAM-101 manufacturing is expected to revolutionize gene therapy. By increasing process capacity threefold ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...